Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Mucinous cystic neoplasm defined by cyst fluid analysis \[23, 28\]:~   * CEA \> 192ng/mL~  * Amylase \< 800 IU/L~  * Cytology negative for malignant cells~  * No communication of cyst with pancreatic duct on 2 imaging studies (EUS, CT, MRCP, or ERCP)~2. Cyst size \> 15mm but \<50mm~3. 3 or fewer cyst compartments~4. Age ≥18 and ≤ 85~Exclusion Criteria:~1. Inability to safely undergo EUS examination with standard conscious sedation~2. Inability for safe FNA needle insertion into the cyst (eg: intervening vessel)~3. Inability to undergo MRI (metal implants/cardiac pacemaker/defibrillator, claustrophobia)~4. Coagulopathy (INR\>1.5 or platelets\<50)~5. Active pancreatitis or pancreatic infection~6. Active sepsis/bacteremia~7. Inability to provide informed consent~8. Pregnancy~9. Breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Ethanol and Paclitaxel Injection (Type: EXPERIMENTAL): All patients will receive at least one treatment with alcohol and paclitaxel.

Based on this trial design, predict the completion outcome and termination type (if applicable).